TMQ vs. GNOM
TMQ (Trilogy Metals Inc.) is a stock, while GNOM (Global X Genomics & Biotechnology ETF) is Health & Biotech Equities fund tracking the Solactive Genomics Index. Over the past 5 years, TMQ returned 8.95%/yr vs -10.84%/yr for GNOM. At a 0.24 correlation, their price movements are largely independent.
Performance
TMQ vs. GNOM - Performance Comparison
Loading charts...
Returns By Period
In the year-to-date period, TMQ achieves a -14.15% return, which is significantly lower than GNOM's 13.87% return.
TMQ
- 1D
- -2.37%
- 1M
- -9.09%
- YTD
- -14.15%
- 6M
- -22.76%
- 1Y
- 172.06%
- 3Y*
- 89.93%
- 5Y*
- 8.95%
- 10Y*
- 22.41%
GNOM
- 1D
- -0.60%
- 1M
- 11.22%
- YTD
- 13.87%
- 6M
- 9.26%
- 1Y
- 60.77%
- 3Y*
- 2.58%
- 5Y*
- -10.84%
- 10Y*
- —
TMQ vs. GNOM - Yearly Performance Comparison
| 2026 (YTD) | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | |
|---|---|---|---|---|---|---|---|---|
TMQ Trilogy Metals Inc. | -14.15% | 271.55% | 169.77% | -21.82% | -66.67% | -17.50% | -23.08% | 3.59% |
GNOM Global X Genomics & Biotechnology ETF | 13.87% | 18.65% | -15.99% | -8.63% | -36.27% | -15.93% | 51.52% | 2.03% |
Correlation
The correlation between TMQ and GNOM is 0.26, which is low. Their price movements are largely independent, making them effective diversification partners.
| Correlation | |
|---|---|
Correlation (1Y) Calculated over the trailing 1-year period | 0.26 |
Correlation (3Y) Calculated over the trailing 3-year period | 0.21 |
Correlation (5Y) Calculated over the trailing 5-year period | 0.23 |
Correlation (All Time) Calculated using the full available price history since Apr 10, 2019 | 0.24 |
Compare stocks, funds, or ETFs
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
Return for Risk
TMQ vs. GNOM — Risk / Return Rank
TMQ
GNOM
TMQ vs. GNOM - Risk-Adjusted Trends Comparison
This table presents a comparison of risk-adjusted performance metrics for Trilogy Metals Inc. (TMQ) and Global X Genomics & Biotechnology ETF (GNOM). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.
Values are calculated on a 1-year rolling basis and updated daily. Risk-adjusted metrics are more stable over longer periods — use the period switch above to explore them.
| TMQ | GNOM | Difference | |
|---|---|---|---|
| Sharpe ratioReturn per unit of total volatility | -1.50 | ||
| Sortino ratioReturn per unit of downside risk | +0.90 | ||
| Omega ratioGain probability vs. loss probability | 1.49 | 1.35 | +0.14 |
| Calmar ratioReturn relative to maximum drawdown | 2.49 | 3.36 | -0.87 |
| Martin ratioReturn relative to average drawdown | 3.56 | 9.65 | -6.08 |
Loading charts...
Drawdowns
TMQ vs. GNOM - Drawdown Comparison
The maximum TMQ drawdown since its inception was -96.55%, which is greater than GNOM's maximum drawdown of -75.00%. Use the drawdown chart below to compare losses from any high point for TMQ and GNOM.
Loading charts...
Drawdown Indicators
| TMQ | GNOM | Difference | |
|---|---|---|---|
Max DrawdownLargest peak-to-trough decline | -96.55% | -75.00% | -21.55% |
Max Drawdown (1Y)Largest decline over 1 year | -69.62% | -18.17% | -51.45% |
Max Drawdown (3Y)Largest decline over 3 years | -69.62% | -44.24% | -25.38% |
Max Drawdown (5Y)Largest decline over 5 years | -85.43% | -72.29% | -13.14% |
Max Drawdown (10Y)Largest decline over 10 years | -88.01% | — | — |
Current DrawdownCurrent decline from peak | -65.09% | -52.95% | -12.14% |
Average DrawdownAverage peak-to-trough decline | -71.91% | -40.62% | -31.29% |
Ulcer IndexDepth and duration of drawdowns from previous peaks | 48.51% | 6.32% | +42.19% |
Volatility
TMQ vs. GNOM - Volatility Comparison
Trilogy Metals Inc. (TMQ) has a higher volatility of 23.54% compared to Global X Genomics & Biotechnology ETF (GNOM) at 9.42%. This indicates that TMQ's price experiences larger fluctuations and is considered to be riskier than GNOM based on this measure. The chart below showcases a comparison of their rolling one-month volatility.
Loading charts...
Volatility by Period
| TMQ | GNOM | Difference | |
|---|---|---|---|
Volatility (1M)Calculated over the trailing 1-month period | 23.54% | 9.42% | +14.12% |
Volatility (6M)Calculated over the trailing 6-month period | 60.07% | 20.56% | +39.51% |
Volatility (1Y)Calculated over the trailing 1-year period | 236.14% | 27.34% | +208.80% |
Volatility (5Y)Calculated over the trailing 5-year period, annualized | 128.53% | 33.68% | +94.85% |
Volatility (10Y)Calculated over the trailing 10-year period, annualized | 101.16% | 34.18% | +66.98% |
Dividends
TMQ vs. GNOM - Dividend Comparison
TMQ has not paid dividends to shareholders, while GNOM's dividend yield for the trailing twelve months is around 1.21%.
| Position | TTM | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|---|---|---|
GNOM Global X Genomics & Biotechnology ETF | 1.21% | 1.37% | 0.00% | 0.00% | 0.00% | 0.03% | 0.14% |
TMQ Trilogy Metals Inc. | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
Frequently Asked Questions
TMQ and GNOM have a correlation of 0.26, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.
TMQ has higher volatility (23.54%) compared to GNOM (9.42%). In terms of maximum drawdown, TMQ dropped -96.55% vs GNOM's -75.00%.
GNOM currently has the higher Sharpe Ratio (2.24 vs 0.73), meaning it's delivered slightly more return per unit of risk over the trailing 12 months. However, this ranking shifts over time - use the Risk/Return Score above for a more comprehensive view that combines Sharpe, Sortino, and other measures used by quantitative funds.
Find the right allocation for TMQ and GNOM
Add both to a portfolio and optimize allocations for your target — whether that's maximizing returns, minimizing drawdowns, or balancing risk across holdings.
Open Portfolio Optimizer